Cargando…
Prostaglandin E2 affects differently the release of inflammatory mediators from resident macrophages by LPS and muramyl tripeptides.
LPS and MTP-PE (liposome-encapsulated N-acetyl-muramyl-L-alanyl-D-isoglutaminyl-L-alanine-2-:[1',2'dipalmitoyl -sni-glycero-3-(hydroxy-phosphoryl-oxyl)] etylamide) induce in liver macrophages a synthesis and release of TNF-alpha, nitric oxide and prostanoids. Both agents induce an expressi...
Autores principales: | Dieter, P, Hempel, U, Kamionka, S, Kolada, A, Malessa, B, Fitzke, E, Tran-Thi, T A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781814/ https://www.ncbi.nlm.nih.gov/pubmed/10815618 |
Ejemplares similares
-
Muramyl Tripeptide Plus Chemotherapy Reduces Metastasis in Non-Metastatic Osteosarcoma: A Single-Center Experience
por: Taçyıldız, Nurdan, et al.
Publicado: (2020) -
Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-γ
por: Pahl, Jens HW, et al.
Publicado: (2014) -
The regulatory role of prostaglandin E(2 )in liver (patho) physiology is controlled at its site of synthesis and its action on the receptors
por: Dieter, Peter, et al.
Publicado: (2004) -
Therapy of human ovarian cancer xenografts with intraperitoneal liposome encapsulated muramyl-tripeptide phosphoethanolamine (MTP-PE) and recombinant GM-CSF.
por: Malik, S. T., et al.
Publicado: (1991) -
Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide
Publicado: (1980)